Standout Papers
- A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. (1991)
Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Comprehensive computational design of ordered peptide macrocycles
2017 StandoutScienceNobel
A graphene oxide-peptide fluorescence sensor for proteolytically active prostate-specific antigen
2012
Effects of Noninhibitory α-1-Antitrypsin on Primary Human Monocyte Activation in Vitro
2001
Tumor-targeting peptides from combinatorial libraries
2016
Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
2005
Single Domain Antibodies Derived from Dromedary Lymph Node and Peripheral Blood Lymphocytes Sensing Conformational Variants of Prostate-specific Antigen
2004
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
2010
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms
2000 Standout
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Wearable biosensors for healthcare monitoring
2019 Standout
1,2-Fucosylated and -N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer
2009
DNA‐Coated AFM Cantilevers for the Investigation of Cell Adhesion and the Patterning of Live Cells
2008 StandoutNobel
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Taking advantage of luminescent lanthanide ions
2005 Standout
Therapeutic cancer targeting peptides
2002
Defensins: antimicrobial peptides of innate immunity
2003 Standout
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Unleashing the therapeutic potential of human kallikrein-related serine proteases
2015
Cells on chips
2006 StandoutNature
Prostate specific antigen: biology, biochemistry and available commercial assays
2001
Tumor targeting with a selective gelatinase inhibitor
1999
Biosensor developments: application to prostate-specific antigen detection
2007
Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion
1999
A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
2000
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels
2015 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms
2002 Standout
Survey of the year 2000 commercial optical biosensor literature
2001
Enzyme-triggered gelation: targeting proteases with internal cleavage sites
2013
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
KiSS-1 Represses 92-kDa Type IV Collagenase Expression by Down-regulating NF-κB Binding to the Promoter as a Consequence of IκBα-induced Block of p65/p50 Nuclear Translocation
2001
Comparative Population Genomics of the Ejaculate in Humans and the Great Apes
2013 StandoutNobel
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Immunotherapy for prostate cancer
2006
Gold nanorods and their plasmonic properties
2012 Standout
False-positive screening results in the Finnish prostate cancer screening trial
2010
Survey of the year 2003 commercial optical biosensor literature
2004
Screening for Prostate Cancer in U.S. Men
2008
Targeted drug delivery for cancer therapy: the other side of antibodies
2012
Signal amplification on planar and gel-type sensor surfaces in surface plasmon resonance-based detection of prostate-specific antigen
2004
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
2002
Evolution of the Hominoid Semenogelin Genes, the Major Proteins of Ejaculated Semen
2003
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Cell-laden microengineered gelatin methacrylate hydrogels
2010 Standout
Paneth cell trypsin is the processing enzyme for human defensin-5
2002
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Analytical performance of the Roche total and free PSA assays on the Elecsys 2010 immunoanalyzer
2002
Prostatic Specific Antigen
1994
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Supramolecular biomaterials
2015 Standout
The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54
2001 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
Time-Resolution in Fluorometry Technologies, Labels, and Applications in Bioanalytical Assays
2001
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
2014
Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves
1994
Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
1994
Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum
1995
Transport phenomena in nanofluidics
2008 Standout
The Proportion of Prostate-specific Antigen (PSA) Complexed to α1-Antichymotrypsin Improves the Discrimination between Prostate Cancer and Benign Prostatic Hyperplasia in Men with a Total PSA of 10 to 30 μg/L
2002
Electrochemiluminescence (ECL)
2004 Standout
Piezoelectric Nanogenerators Based on Zinc Oxide Nanowire Arrays
2006 StandoutScience
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures
2017 StandoutNobel
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
2002
The Serpin MNEI Inhibits Elastase-like and Chymotrypsin-like Serine Proteases through Efficient Reactions at Two Active Sites
2001
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Inhibition of Prostate-Specific Antigen (PSA) by α1-Antichymotrypsin: Salt-Dependent Activation Mediated by a Conformational Change
2002
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Diversity Oriented Clicking (DOC): Divergent Synthesis of SuFExable Pharmacophores from 2‐Substituted‐Alkynyl‐1‐Sulfonyl Fluoride (SASF) Hubs
2020 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Lanthanide-Based Luminescent Hybrid Materials
2009 Standout
Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms
1998
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
A new method for non-labeling attomolar detection of diseases based on an individual gold nanorod immunosensor
2011
Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
1995
Supersensitive Time-resolved Immunofluorometric Assay of Free Prostate-specific Antigen with Nanoparticle Label Technology
2001
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
From Combinatorial Chemistry to Cancer-Targeting Peptides
2007
Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases
2005
In situclick chemistry: from small molecule discovery to synthetic antibodies
2012
Works of Jari Leinonen being referenced
Activation of Type IV Procollagenases by Human Tumor-associated Trypsin-2
1997
Identification of novel prostate‐specific antigen‐binding peptides modulating its enzyme activity
2000
Novel Peptide Inhibitors of Human Kallikrein 2
2006
Prostate-specific antigen
1999
Prostate-specific antigen forms a complex with and cleaves α1-protease inhibitor in vitro
1997
Prostate-specific antigen and other prostate cancer markers
2000
Activity and stability of human kallikrein‐2‐specific linear and cyclic peptide inhibitors
2007
Separation of enzymatically active and inactive prostate‐specific antigen (PSA) by peptide affinity chromatography
2003
Monoclonal Antibodies, Immunofluorometric Assay, and Detection of Human Semenogelin in Male Reproductive Tract: No Association with In Vitro Fertilizing Capacity of Sperm1
2002
Time-resolved Immunofluorometric Assay of Trypsin-1 Complexed with α1-Antitrypsin in Serum: Increased Immunoreactivity in Patients with Biliary Tract Cancer
1999
Immunopeptidometric Assay for Enzymatically Active Prostate-Specific Antigen
2004
Characterization of Monoclonal Antibodies for Prostate-specific Antigen and Development of Highly Sensitive Free Prostate-specific Antigen Assays
1999
Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
2000
USE OF THE COMPLEX BETWEEN PROSTATE SPECIFIC ANTIGEN AND α1-PROTEASE INHIBITOR FOR SCREENING PROSTATE CANCER
2000
Measurement of the Complex between Prostate-specific Antigen and α1-Protease Inhibitor in Serum
1999
Complex Formation Between PSA Isoenzymes and Protease Inhibitors
1996
VALIDITY OF THE PROSTATE SPECIFIC ANTIGEN TEST FOR PROSTATE CANCER SCREENING: FOLLOWUP STUDY WITH A BANK OF 21,000 SERA IN FINLAND
2001
A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
1991 Standout